Source: Economic Daily - China Economic Network
Beijing, January 19 (China Economic Network) -- On January 18, the Sichuan Provincial Drug Administration published an information disclosure form on administrative punishment cases, showing that six pharmaceutical companies, namely Sichuan Baili Pharmaceutical Co., Ltd., Sichuan Dahuaxi Pharmaceutical Co., Ltd., Chengdu Ji'ankang Pharmaceutical Co., Ltd., Sichuan Tongzhengtang Chinese Medicine Tablet Co., Ltd., Sichuan Wusheng Pharmaceutical Group Co., Ltd., and Sichuan Limin Chinese Medicine Tablet Co., Ltd., were administratively punished.
Among them, Sichuan Baili Pharmaceutical Co., Ltd. was punished by the Sichuan Provincial Drug Administration with a warning for not complying with the Good Manufacturing Practices for Drugs and violating the first paragraph of Article 43 of the Drug Administration Law (2019 Revised Edition).
According to Tianyan, Sichuan Baili Pharmaceutical Co., Ltd. was established in 1996 with a registered capital of 105 million yuan, and the company's legal person and suspected actual controller are Zhu Yi. Under Zhu Yi's name, Sichuan Baili Tianheng Pharmaceutical Co., Ltd. holds 100% of the equity of Sichuan Baili Pharmaceutical Co., Ltd.
